Health Canada Clarifies Position On Biosimilar Switching
As part of its update to a fact sheet on biologics and biosimilars, Health Canada has clarified its position on biosimilar switching.
You may also be interested in...
As momentum continues for biosimilar switching programs in Canada, Yukon has become the latest jurisdiction to announce such an initiative.
Ontario has joined several other Canadian provinces and territories by implementing a biosimilar switching policy for Ontarians taking biologic drugs.
Saskatchewan has become the latest Canadian province to introduce a biosimilar switching scheme, adding further momentum to the roll-out of similar initiatives across Canada.